Document Type : Original Article
Authors
- Yousef Khanjari 1
- Morteza Oladnabi 2
- Nafiseh Abdollahi 3
- Ahmad Heidari 4
- Saeed Mohammadi 5
- Alijan Tabarraei 6
1 Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
2 Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
3 Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
4 Department of Research and Technology, Golestan University of Medical Sciences, Gorgan, Iran.
5 Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran
6 Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, IR Iran.
Abstract
Background: Programmed cell death protein 1 (PD-1) is a negative costimulatory molecule with immunomodulatory properties. Recently, PD-1 gene defects have attracted attention in the pathogenesis of SLE. Objective: Here, we assessed the association of PD-1 gene polymorphisms in intron 4 and haplotypes with the susceptibility to SLE. Method: Seventy-six SLE patients and 159 healthy controls were included. We screened the polymorphisms by amplifying the intron 4 of the PD-1 gene with the specific primers followed by sequencing. Results: Two distinct SNPs were identified (rs6705653 and rs41386439) within the intron 4 of the PD-1 gene. The AA genotype of +7499 (G/A) SNP was associated with the higher risk of SLE [OR=3.31, 95% CI (1.25-8.76), p-value=0.045], while A allele was identified as a risk allele [OR=1.75, 95% CI (1.10-2.76), p-value=0.015]. However, no significant association was observed between the allele and the genotype frequencies of +7209 (C/T) polymorphic region of the PD-1 gene and susceptibility to SLE. Haplotype analysis showed the significantly higher presence of H2 haplotype (AC; +7499/+7209) [OR=1.70, 95% CI (1.24-2.33), p-value=0.0012] in SLE patients. Conclusion: To the best of our knowledge, this is the first report of the significant association of PD-1 +7499 (G/A) SNP with the SLE susceptibility and the first detection of both polymorphic loci in a population from Iran. However, more investigations are necessary to confirm these findings.
Keywords
)